Pender Fund Capital Management Ltd. Surmodics Inc Transaction History
Pender Fund Capital Management Ltd.
- $132 Million
- Q3 2024
A detailed history of Pender Fund Capital Management Ltd. transactions in Surmodics Inc stock. As of the latest transaction made, Pender Fund Capital Management Ltd. holds 11,100 shares of SRDX stock, worth $437,784. This represents 0.32% of its overall portfolio holdings.
Number of Shares
11,100
Previous 10,600
4.72%
Holding current value
$437,784
Previous $445,000
3.37%
% of portfolio
0.32%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding SRDX
# of Institutions
126Shares Held
11.8MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$46.2 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$41 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$39 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$31.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$29.7 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $552M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...